For more information please contact +1 (888) 605-6579

Post-Operative Sepsis

Sepsis is an extremely deadly disease characterized by whole body inflammation. Sepsis literally means the state of putrefaction or decay. It is an immune system attack on the body in response to microbes in the blood, urine, skin or other tissues. Usually patients are treated in the intensive care unit of the hospital, especially when this disease is developed postoperatively.. Studies have shown that certain types of the thymus Live Cell Extract can have a positive effect on patients suffering from post-operative sepsis. Consider the following.

Post-Operative Sepsis and Live Cell Therapy

The thymus extracts thymalin and t-activin were used in a study involving postoperative sepsis. The study showed after 14 days of treatment that thymalin stimulated T cells while acting with immunoglobulins. T-activin increased the numbers of T and B cells. Clinical improvement was best when the thymus extracts were used in combination with other medication.  Immunological and clinical studies demonstrated that immunodeficiency is the most probable cause of postoperative complications.  This was especially true following reparative surgery of the facial bones. Results were presented for 10 cases of facial surgery for congenital and acquired deformation using t-activin conjointly with surgery. This treatment normalized the immune system and prevented the development of postoperative complications in all of the patients during this study.

Post-Surgical Infection

Post-Surgical Infections are becoming more and more common in hospitals, especially in the United States. There are many reports and case studies as to the use of cell therapies to reduce the risk of postsurgical infections. These case studies prove one thing: thymus extract can drastically boost immunity in both infants and adults with excellent results.

Post-Surgical Infection and Live Cell Therapy

One study was performed on 425 patients undergoing colon-rectal surgery. Due to the nature of this procedure patients commonly suffer from postoperative infections. In this study, patients were given thymus extract 2 days before surgery and 5 days after surgery in addition to their antibiotic regimen.

Patients receiving thymus displayed a lower incidence of postsurgical infections and abscesses compared to those who received only antibiotic therapy. This was even the case in patients whose immune system was compromised.  Respiratory tract infections were 50% less frequent in the group receiving thymus as compared to those who were only receiving antibiotics.

Also, forty-seven infants with sepsis and 34 with localized infection were given T-activin thymus extract as a part of the post-surgical care, while 75 other infants were treated with conventional methods. Results showed that the clinical course of SSI was less severe in the patients receiving thymus extract with more pronounced positive changes in symptoms, shortened hospital stay, and decreased mortality in the treated infants.  The study indicated that the postoperative use of thymus extracts in infants  led to an increase in the number and function of the T-lymphocytes with improved bactericidal activity of circulating phagocytes in  postoperative newborns with SSI. In other words, thymus extract can really support a healthy immune system. Those with SSI are typically extremely vulnerable already.  Despite being young, they have a severe medical condition. That is why specialists have developed a noninvasive thymus spray, which can be administered under the infants tongue with little or no fuss. This “boosting of immunity” is just what the infant needs to stay healthy while he or she recuperates.

Melanoma

Melanoma is a dangerous form of skin cancer that is relatively common. The risk factors for developing melanoma may include some of the following:

 

  • Living in sunny climates
  • Long-term exposure to high levels of strong sunlight
  • Blistering sunburns during childhood
  • Use of tanning booths
  • Close relatives with a history of melanoma
  • Exposure to carcinogens
  • Certain types of moles
  • Weakened immune system

Melanoma and Live Cell Therapy

One study on immune modulation using thymus gland extract was performed on a group of patients with early stage melanoma. Interestingly, there were no significant benefits seen regarding the immune reaction to the cancer or in a lengthening of the disease-free period. This study did show that the overall survival rate was nearly twice as long compared to melanoma patients who did not use thymus extract.

Breast Cancer

Breast cancer has seen an alarming rise in the number of victims who currently suffer from it. It has claimed countless lives. The astonishing thing is that now even some men are being affected. However the majority of the victims are women. Our mothers, sisters and wives are all at risk. If breast cancer runs in your family you are, for obvious reasons, at an increased risk. However, there is hope. Case studies have been conducted with the Live Cell Extract thymostimulin, and the results are promising.

Breast Cancer and Live Cell Therapy

Eighty-five patients with advanced breast cancer, who had previously undergone mastectomy and were currently undergoing chemotherapy, were included in a study dividing patients into 2 matching groups. One group was treated with chemotherapy and thymostimulin (live cell thymus extract) while the control group was treated with chemotherapy alone. The group receiving thymostimulin experienced approximately 1/2 the mild to severe leukopenia (reduction in number of white blood cells) as the control group.  A reduction in infections, in addition to the above results, confirmed the value of immunotherapy during chemotherapy for breast cancer.

A similar study using thymostimulin found no significant statistical differences in immunologic or hematologic values between those receiving chemotherapy alone or with thymostimulin.  However, the researchers observed that administration of the thymic hormone appeared to protect the bone marrow, and the subjects receiving thymostimulin had a lower incidence of side effects than the untreated group.

Another study involving the use of thymus extracts with breast cancer included 26 women suffering from breast carcinoma who had previously undergone mastectomy 1 to 2 years before the study began. Most had also undergone a removal of the underarm tissue.  Each subject received intramuscular injections of Thymus Extract Mulli twice weekly for 4 to 6 weeks. All subjects were monitored using the carcinoembryonic antigen (a glycoprotein involved in cell adhesion) test. Results showed a reduction of carcinoembryonic antigen values in approximately 70% of the cases treated with thymus extracts compared to 47% for controls. The authors concluded that because of its effectiveness and lack of side effects, immunotherapy is valuable and should be seriously considered as a therapy in breast cancer.

Cancer Therapy

Cell therapies are commonly used in Europe as an addition to traditional cancer treatment. Many patients look for alternative options to chemotherapy.  International statistics show that chemotherapy has only about a 2% success rate. While mainstream cancer therapies most definitely have their place in the treatment of cancer, no major advancements have been made in the last 25 years despite the release of many new drugs. For this reason, cell therapy   is an excellent additional therapy that may be able to improve outcomes of therapy.

Complementary cell therapy in the treatment of cancer has 2 functions:

  • Immune modulation using thymus
  • Organ fortification and rejuvenation with organ specific extracts

 

Examples of the use of Cell Therapy

Lung Cancer

Thymus extract was given twice a week for 10 weeks to 12 patients suffering from either undifferentiated cell carcinoma or squamous cell carcinoma.

Results:

  • Subjective and objective clinical improvements were seen in 10 of the 12 patients.
  • Local tumor growth was stopped and metastatic spread to mediastinal lymph nodes or other organs was decreased.
  • 3 patients experienced a partial regression of tumor mass.
  • The 6 month survival rate was increased to 42% in the treated group, compared to 7% in the control group    receiving only symptomatic treatment

Skotnicki published these results in 1989.

 

Hodgkin’s disease (lymphogranulomatosis)

Thymus extract was used in a program involving 366 children suffering from Hodgkin’s disease. These children also had other immune disorders.

Results:

  • There was an improvement in their immune system parameters.
  • 93.8% of the cases reached the 5-year survival rate compared to 70-80% of cases treated with radiation and chemotherapy

These results were published in 1991 -92 by Berkow and Makhonova

 

Breast Cancer

A group of 26 women with breast cancer was treated with thymus extract twice a week for 4-6 weeks. These women had previously undergone mastectomy 1 to 2 years before the study began.

Results:

  •  The CEA tumor marker dropped in approximately 70% of the cases treated with thymus extracts. This is compared to    47% in the group not undergoing cell therapy.

Another  study conducted over 15 years on 457 patients suffering breast cancer as well as cancer of the gastrointestinal tract showed that patients receiving cell therapy had:

  •  Less post-operative complications
  • Better and faster wound healing
  • Increased survival time compared to subjects receiving no cell therapy

 

Liver Cancer

A small pilot study on patients treated with thymus extract alone showed tumor regression in almost 50% of cases.

Anti-Aging

Anti-aging sounds like a dream, but in fact cell therapy may make a big difference as to how you look and how you feel.  Dr. Jonathan V. Wright wrote an interesting report about Live Cell Therapy entitled, “How pigs can help you look and feel 15 years younger in just three months”

The basis for anti-aging is thymus extract therapy. Due to the reduction of size of the thymus gland during our life cycle, the thymic related immune response becomes less the older we get. When we reach 50 years old, only about 15% still functions. This leads to a significant increase in infections, cancer, and auto-immune diseases increasing as we get older.

Usually a course of thymus injections is given twice a week for 6 weeks. After this, organ specific extracts are given to boost the hormone production in the body. This cocktail contains extracts of most major organs and structures in the body, as well as glandular extracts.

How might you expect to feel after an anti-aging cell therapy?

Patients report the following:

 

  • A general sensation of feeling younger
  • Skin looks younger and hydrated
  • Lightening of blemishes and facial pigmentation
  • Refining of facial pores and a fresh glow to the skin
  • Skin elasticity and thickness improved
  • Wrinkles are reduced
  • Improvement of sleep quality
  • Improvement of digestion
  • Improvement in blood circulation to the hands and feet
  • Lower blood pressure
  • Improved sex drive and potency
  • Relief from sexual dysfunction
  • Firming of the breasts
  • Relief from symptoms of menopause
  • Relief from PMS
  • Improvement in the immune system
  • A feeling of being awake and alert
  • Higher energy levels
  • Increase in joint flexibility and agility
  • Decrease in weight
  • Improvement of blood parameters
  • Feeling of being alive again

These are all very non-scientific terms, but they are the patient’s own descriptions of how they felt after cell therapy.

Osteoporosis

Osteoporosis is the most common type of bone disease. It involves a thinning of the bones with a loss of bone density. 20% of American women over age 50 suffer from osteoporosis. This disease commonly leads to bone fractures, especially in the wrists, hip or spine.

The most common causes of osteoporosis are a drop in estrogen in women during menopause and a drop in testosterone in men.

Other causes may include:

  • Being confined to a bed
  • Chronic rheumatoid arthritis, chronic kidney disease, eating disorders
  • Taking Cortisone over  an extended period
  • Hyperparathyroidism
  • Vitamin D deficiency
  • Drinking a large amount of alcohol
  • Family history of osteoporosis
  • History of hormone treatment for prostate cancer or breast cancer
  • Low body weight
  • Smoking
  • Lack of calcium in the diet

In the early stage of osteoporosis there are no symptoms. The disease may later become apparent through bone pain or tenderness, or bone fractures may occur for no apparent reason. Older patients may notice that they grow shorter or suddenly develop a hunched back.

 

Cell therapies are used to reduce symptoms and to boost hormone production. Therapy may cause bone density to increase.

Hormonal Dysfunction

Hormonal dysfunction can lead to a whole host of symptoms. These may include:

  • Pre-Menstrual Syndrome
  • Impotence
  • Loss of Libido
  • Hair Loss
  • Mood Swings
  • Fatigue
  • Brain Fog
  • Skin Problems

Cell therapy may be used to balance hormone production. Cell extracts from the adrenal cortex, ovaries, testes, thyroid, and other hormone producing glands are often used in a gender specific cocktail to boost the function of these glands and help to regulate hormone production. As a result many patients report an improvement in their overall state of health and a reduction in the symptoms of hormonal dysfunction.

Auto-Immune Diseases

Cell therapies are ideal components in the treatment of autoimmune diseases. The basis of every cell therapy begins with immune modulation. Through the application of thymus extract the immune function may be normalized, reducing symptoms.

Cell Therapies are typically used to treat the following autoimmune disorders:

  • Addison’s disease
  • Arthritis
  • Asthma
  • Celiac disease
  • Crohn’s Disease
  • Dermatomyositis
  • Grave’s disease
  • Hashimoto’s thyroiditis
  • Lupus erythematosus
  • Multiple sclerosis
  • Myasthenia gravis
  • Pernicious anemia
  • Reactive arthritis
  • Rheumatoid arthritis
  • Sjogren syndrome
  • Systemic Lupus Erythematosus (SLE)
  • Type I diabetes

Patient reports differ as to the effectiveness of cell therapy in the treatment of these symptoms, but the tendency seems to be positive. Below are a few examples:

Systemic Lupus Erythematosus (SLE) and Live Cell Therapy

In one case study, thymus extract was used to test its effect on the cellular immune status of 49 children ages 8-15 suffering from SLE. A week treatment regimen resulted in overall improved health and a reduction of SLE activity. The cellular immune status also improved with  an increase in T-Lymphocyte differentiation. The therapy also resulted in an “elimination and prevention of the development of secondary complications of infections.”

Another study performed on 17 adults with SLE showed an improvement of joint and skin symptoms.